SCHEMBL7305217

SCHEMBL7305217

O=C(c1cccc(C(F)(F)F)c1)N1c2ccccc2OCC1CCO

nearest known ligand 0.72

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.72
ALDH1A1 P00352 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
NR3C2 P08235 8/20 0.47
NR3C1 P04150 4/20 0.47
PGR P06401 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
POLB P06746 2/20 0.45
GAA P10253 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CTNNB1 P35222 1/20 0.43
WNT3A P56704 1/20 0.43
HPGD P15428 1/20 0.43
RBP4 P02753 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7299161 0.91 LMNA (0.71) LMNAALDH1A1NPSR1NR3C2NR3C1
SCHEMBL7302805 0.91 LMNA (0.71) LMNAALDH1A1NPSR1NR3C2NR3C1
SCHEMBL7299169 0.89 LMNA (0.58) LMNANR3C2NR3C1PGRL3MBTL1
SCHEMBL8548928 0.88 LMNA (0.60) LMNAALDH1A1NPSR1NR3C2NR3C1
SCHEMBL7298261 0.88 LMNA (0.58) LMNANR3C2NR3C1PGRPOLB
SCHEMBL7301526 0.86 LMNA (0.62) LMNAALDH1A1NPSR1NR3C2NR3C1
SCHEMBL7302522 0.85 LMNA (0.54) LMNANR3C2NR3C1PGRL3MBTL1
SCHEMBL7300845 0.80 LMNA (0.58) LMNANR3C2NR3C1POLBMEN1
SCHEMBL7305178 0.80 LMNA (0.58) LMNANR3C2NR3C1PGRL3MBTL1
SCHEMBL8543754 0.80 LMNA (0.64) LMNAALDH1A1NPSR1NR3C2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0666260-B1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1999-08-04 EP disclosed
EP-0614893-B1 Benzoxazine derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1998-05-27 EP disclosed
US-5550125-A BRAIN DISORDERS SYNTHELABO (FR) 1996-08-27 US disclosed
CN-1109880-A 3-(2-aminoethyl)-4-[3-(trifluoromethyl) benzoyl]-3,4-dihydro-1,4-benzoxazine derivative and preparation of same SYNTHELABO (FR) 1995-10-11 CN disclosed
US-5447928-A Antiischemic agents and nervous system disorders SYNTHELABO (FR) 1995-09-05 US disclosed
EP-0666260-A1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1995-08-09 EP disclosed
CN-1099032-A Benzoxazine derivatives, their preparation and their use in medicine SYNTHELABO (FR) 1995-02-22 CN disclosed
EP-0614893-A1 Benzoazine derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1994-09-14 EP disclosed